E-DRUG: DFID Paper: Update on China & India - access to medicines
----------------------------------------------------------
E-drug subscribers might be interested in a recently published study by
Cheri Grace at DFID's Health Resource Centre on the access to medicines
impact of patent legislation in India and China. This update of a 2004
study explains recent developments in TRIPS and domestic legislation in
India and China and the practical implications for access to both active
pharmaceutical ingredients and finished products. The study can be
accessed at
http://www.dfid.gov.uk/pubs/files/atm-china-india.pdf
Thanks
Daniel Graymore
Private Sector Adviser
Business Alliances Team and Global AIDS Policy Team
Policy Division
The Department for International Development
+ 44 (0) 20 7023 0204
+ 44 (0) 7768 553 257
http://www.dfid.gov.uk/feedback/
"Daniel Graymore" <D-Graymore@dfid.gov.uk>